Facebook Twitter LinkedIn Instagram Email Printer Google Plus


The recent rise of custom-made drugs is already redefining the state of regulation, society, and the economy.

Researcher, PreScouter

Three percent of consumers drive 70 percent of pharmacy spend. Pharmacy is ripe for change.

Former Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Senior Advisor, Oliver Wyman

How to ensure medications work as intended for different patient populations.

Chief Executive Officer, Aetion
Partner, Health & Life Sciences, Oliver Wyman

Q&A with the Academy of Nutrition and Dietetics on malnutrition's greatest challenges and opportunities

What if your doctor handed out grocery lists, not a grocery list of pills to take?

Chief Science Officer, Academy of Nutrition and Dietetics
Director, Oliver Wyman Health Innovation Center, Oliver Wyman

Physicians are best positioned to curtail the $265 billion wasted annually on unneeded care.

Global Head, Health Services, Oliver Wyman
Professor of Surgery and Health Policy, Johns Hopkins Medicine
Principal, Health and Life Sciences, Oliver Wyman

Insights in your inbox


Once J.P. Morgan Healthcare Week comes to a close, companies will need to show as much as they tell.

Chief Strategist, Health Practice, Edelman

The key to measurement-based digital mental healthcare intervention and assessment? A patient's smartphone.

An examination of how the astronomically deadly and expensive opioid epidemic has generated significant litigation risk for healthcare businesses.

Coverage and Claims Leader, Marsh Casualty

What's around the bend for healthcare venture capital in 2018? We talk Amazon, good and bad M&A, and hitting the investment peak.

Senior Managing Director, GE Ventures